The cAMP/PKA/CREB and TGFβ/SMAD4 Pathways Regulate Stemness and Metastatic Potential in Colorectal Cancer Cells.


Journal

Cancer research
ISSN: 1538-7445
Titre abrégé: Cancer Res
Pays: United States
ID NLM: 2984705R

Informations de publication

Date de publication:
15 11 2022
Historique:
received: 24 04 2022
revised: 28 07 2022
accepted: 30 08 2022
pubmed: 7 9 2022
medline: 18 11 2022
entrez: 6 9 2022
Statut: ppublish

Résumé

This study identifies signaling pathways essential for maintaining the stemness and metastatic potential of colorectal cancer cells and proposes CREB as a therapeutic target in metastatic colorectal cancer.

Identifiants

pubmed: 36066360
pii: 708953
doi: 10.1158/0008-5472.CAN-22-1369
doi:

Substances chimiques

Cyclic AMP Response Element-Binding Protein 0
Cyclic AMP-Dependent Protein Kinases EC 2.7.11.11
Smad4 Protein 0
SMAD4 protein, human 0
Transforming Growth Factor beta 0
CREB1 protein, human 0

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

4179-4190

Informations de copyright

©2022 American Association for Cancer Research.

Auteurs

Teruaki Fujishita (T)

Division of Pathophysiology, Aichi Cancer Center Research Institute, Nagoya, Aichi, Japan.

Yasushi Kojima (Y)

Division of Pathophysiology, Aichi Cancer Center Research Institute, Nagoya, Aichi, Japan.

Rie Kajino-Sakamoto (R)

Division of Pathophysiology, Aichi Cancer Center Research Institute, Nagoya, Aichi, Japan.

Emi Mishiro-Sato (E)

Division of Pathophysiology, Aichi Cancer Center Research Institute, Nagoya, Aichi, Japan.

Yasuhiro Shimizu (Y)

Department of Gastroenterological Surgery, Aichi Cancer Center Hospital, Nagoya, Aichi, Japan.

Waki Hosoda (W)

Department of Pathology and Molecular Diagnostics, Aichi Cancer Center Hospital, Nagoya, Aichi, Japan.

Rui Yamaguchi (R)

Division of Cancer Systems Biology, Aichi Cancer Center Research Institute, Nagoya, Aichi, Japan.
Department of Cancer Informatics, Nagoya University Graduate School of Medicine, Nagoya, Aichi, Japan.

Makoto Mark Taketo (MM)

Colon Cancer Project, Kyoto University Hospital-iACT, Graduate School of Medicine, Kyoto University, Yoshida-Konoe-cho, Sakyo-ku, Kyoto, Japan.

Masahiro Aoki (M)

Division of Pathophysiology, Aichi Cancer Center Research Institute, Nagoya, Aichi, Japan.
Department of Cancer Physiology, Nagoya University Graduate School of Medicine, Nagoya, Aichi, Japan.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH